Tianjin Ringpu Bio Tech (300119) — Financial Flexibility Index
Tianjin Ringpu Bio Tech (300119) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥128.27 Million (operating CF CN¥105.02 Million minus capex CN¥23.24 Million) represents 0% of total liabilities (CN¥2.54 Billion). Check 300119 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Ringpu Bio Tech Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Tianjin Ringpu Bio Tech across 19 annual periods. See Tianjin Ringpu Bio Tech short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tianjin Ringpu Bio Tech (2007–2025)
Year-by-year free cash flow to debt coverage for Tianjin Ringpu Bio Tech. For the full company profile including market capitalisation, see Tianjin Ringpu Bio Tech market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥473.64 Million | CN¥297.53 Million | CN¥2.47 Billion | ▼ -38.4% |
| 2024 | 0.31x | CN¥920.88 Million | CN¥735.55 Million | CN¥2.96 Billion | ▼ -10.5% |
| 2023 | 0.35x | CN¥622.68 Million | CN¥378.20 Million | CN¥1.79 Billion | ▼ -26.8% |
| 2022 | 0.47x | CN¥761.92 Million | CN¥389.49 Million | CN¥1.61 Billion | ▼ -5.7% |
| 2021 | 0.50x | CN¥688.50 Million | CN¥382.63 Million | CN¥1.37 Billion | ▼ -9.6% |
| 2020 | 0.56x | CN¥647.61 Million | CN¥388.44 Million | CN¥1.16 Billion | ▲ +9.6% |
| 2019 | 0.51x | CN¥613.31 Million | CN¥383.61 Million | CN¥1.21 Billion | ▲ +31.7% |
| 2018 | 0.39x | CN¥287.33 Million | CN¥174.88 Million | CN¥744.03 Million | ▲ +33.5% |
| 2017 | 0.29x | CN¥216.44 Million | CN¥107.57 Million | CN¥747.95 Million | ▼ -45.9% |
| 2016 | 0.53x | CN¥335.80 Million | CN¥207.67 Million | CN¥627.74 Million | ▼ -17.6% |
| 2015 | 0.65x | CN¥376.36 Million | CN¥225.27 Million | CN¥579.77 Million | ▼ -46.4% |
| 2014 | 1.21x | CN¥311.48 Million | CN¥128.37 Million | CN¥257.23 Million | ▲ +0.7% |
| 2013 | 1.20x | CN¥340.29 Million | CN¥88.68 Million | CN¥282.89 Million | ▼ -3.2% |
| 2012 | 1.24x | CN¥257.29 Million | CN¥89.92 Million | CN¥206.99 Million | ▼ -20.9% |
| 2011 | 1.57x | CN¥275.10 Million | CN¥90.29 Million | CN¥175.12 Million | ▲ +91.4% |
| 2010 | 0.82x | CN¥160.61 Million | CN¥112.82 Million | CN¥195.66 Million | ▲ +39.2% |
| 2009 | 0.59x | CN¥95.93 Million | CN¥64.59 Million | CN¥162.63 Million | ▼ -42.7% |
| 2008 | 1.03x | CN¥87.73 Million | CN¥68.07 Million | CN¥85.18 Million | ▲ +43.2% |
| 2007 | 0.72x | CN¥36.14 Million | CN¥19.15 Million | CN¥50.26 Million | — |